نتایج جستجو برای: cellcept

تعداد نتایج: 65  

Journal: :Journal of the American Society of Nephrology : JASN 2003
William M Bennett

Over the past decade, immunosuppression for renal transplantation has shifted from predominantly azathioprine-based regimens to those containing mycophenolic acid (MMF, CellCept) (1). In most centers, MMF is combined with cyclosporine or tacrolimus (calcineurin inhibitors) plus corticosteroid therapy. These combinations have led to unprecedented patient and graft survivals over the near term (1...

Journal: :Kidney international 1999
M H Sayegh

renal transplant dysfunction, as manifested by a slow, progressive rise in serum creatinine, developed; the decreasing renal function was associated with proteinuria (1 to 2 g/24 hr). The erratic cyclosporine levels and blood pressure readings led to the suspicion that he remained noncompliant with his medications. A renal transplant biopsy one year ago (when his serum creatinine was 4.0 mg/dl ...

Journal: :Health technology assessment 2016
Tracey Jones-Hughes Tristan Snowsill Marcela Haasova Helen Coelho Louise Crathorne Chris Cooper Ruben Mujica-Mota Jaime Peters Jo Varley-Campbell Nicola Huxley Jason Moore Matt Allwood Jenny Lowe Chris Hyde Martin Hoyle Mary Bond Rob Anderson

BACKGROUND End-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation, followed by immunosuppressive therapy (induction and maintenance therapy) to reduce the risk of kidney rejection and prolong graft survival. OBJECTIVES To rev...

2008
Jelka Masin-Spasovska Goce Spasovski Ladislava Grcevska Sonja Dzikova Zivko Popov Gordana Petrusevska Ljupco Lekovski Ninoslav Ivanovski

Aims: The aim of the present study was to identify subclinical rejections (SR) and histological markers of chronic allograft nephropathy (CAN) in protocol biopsies at 1 in living related kidney transplantation and the possible implications of these findings on the graft function. Methods: Protocol graft biopsies at the first month after transplantation were obtained in 23 living related allogra...

Journal: :Health technology assessment 2016
Marcela Haasova Tristan Snowsill Tracey Jones-Hughes Louise Crathorne Chris Cooper Jo Varley-Campbell Ruben Mujica-Mota Helen Coelho Nicola Huxley Jenny Lowe Jan Dudley Stephen Marks Chris Hyde Mary Bond Rob Anderson

BACKGROUND End-stage renal disease is a long-term irreversible decline in kidney function requiring kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation followed by induction and maintenance immunosuppressive therapy to reduce the risk of kidney rejection and prolong graft survival. OBJECTIVES To systematically review and update the evid...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید